Cargando…

SARS-CoV-2 sero-prevalence in the workforces of three large workplaces in South Wales: a sero-epidemiological study

BACKGROUND: Sero-prevalence studies quantify the proportion of a population that has antibodies against SARS-CoV-2, and can be used to identify the extent of the COVID-19 pandemic at a population level. The aim of the study was to assess the sero-prevalence of SARS-CoV-2 antibodies in the workforce...

Descripción completa

Detalles Bibliográficos
Autores principales: Puchades, Alice, Daniel, Rhian, Geen, John, Peden, Jo, Lewis, Heather, Nnoaham, Kelechi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8785373/
https://www.ncbi.nlm.nih.gov/pubmed/35073884
http://dx.doi.org/10.1186/s12889-021-12478-x
_version_ 1784638950389841920
author Puchades, Alice
Daniel, Rhian
Geen, John
Peden, Jo
Lewis, Heather
Nnoaham, Kelechi
author_facet Puchades, Alice
Daniel, Rhian
Geen, John
Peden, Jo
Lewis, Heather
Nnoaham, Kelechi
author_sort Puchades, Alice
collection PubMed
description BACKGROUND: Sero-prevalence studies quantify the proportion of a population that has antibodies against SARS-CoV-2, and can be used to identify the extent of the COVID-19 pandemic at a population level. The aim of the study was to assess the sero-prevalence of SARS-CoV-2 antibodies in the workforce at three workplaces: a food factory, non-food factory and call-centre. METHODS: Nine hundred ninety-three participants were recruited from three workplaces in South Wales. Participants completed a questionnaire and had a lateral flow point-of-care SARS-CoV-2 antibody test administered by a healthcare professional. The data were analysed using multivariable logistic regression, both using complete records only and following multiple imputation. RESULTS: The sero-prevalence of SARS-CoV-2 antibodies ranged from 4% (n = 17/402) in the non-food factory to 10% (n = 28/281) in the food factory (OR 2.93; 95% CI 1.26 to 6.81). After taking account of confounding factors evidence of a difference remained (cOR comparing food factory to call centre (2.93; 95% CI 1.26 to 6.81) and non-food factory (3.99; 95% CI 1.97 to 8.08) respectively). The SARS-CoV-2 antibody prevalence also varied between roles within workplaces. People working in office based roles had a 2.23 times greater conditional odds (95% CI 1.02 to 4.87) of being positive for SARS-CoV-2 antibodies than those working on the factory floor. CONCLUSION: The sero-prevalence of SARS-CoV-2 antibodies varied by workplace and work role. Whilst it is not possible to state whether these differences are due to COVID-19 transmission within the workplaces, it highlights the importance of considering COVID-19 transmission in a range of workplaces and work roles.
format Online
Article
Text
id pubmed-8785373
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-87853732022-01-25 SARS-CoV-2 sero-prevalence in the workforces of three large workplaces in South Wales: a sero-epidemiological study Puchades, Alice Daniel, Rhian Geen, John Peden, Jo Lewis, Heather Nnoaham, Kelechi BMC Public Health Research BACKGROUND: Sero-prevalence studies quantify the proportion of a population that has antibodies against SARS-CoV-2, and can be used to identify the extent of the COVID-19 pandemic at a population level. The aim of the study was to assess the sero-prevalence of SARS-CoV-2 antibodies in the workforce at three workplaces: a food factory, non-food factory and call-centre. METHODS: Nine hundred ninety-three participants were recruited from three workplaces in South Wales. Participants completed a questionnaire and had a lateral flow point-of-care SARS-CoV-2 antibody test administered by a healthcare professional. The data were analysed using multivariable logistic regression, both using complete records only and following multiple imputation. RESULTS: The sero-prevalence of SARS-CoV-2 antibodies ranged from 4% (n = 17/402) in the non-food factory to 10% (n = 28/281) in the food factory (OR 2.93; 95% CI 1.26 to 6.81). After taking account of confounding factors evidence of a difference remained (cOR comparing food factory to call centre (2.93; 95% CI 1.26 to 6.81) and non-food factory (3.99; 95% CI 1.97 to 8.08) respectively). The SARS-CoV-2 antibody prevalence also varied between roles within workplaces. People working in office based roles had a 2.23 times greater conditional odds (95% CI 1.02 to 4.87) of being positive for SARS-CoV-2 antibodies than those working on the factory floor. CONCLUSION: The sero-prevalence of SARS-CoV-2 antibodies varied by workplace and work role. Whilst it is not possible to state whether these differences are due to COVID-19 transmission within the workplaces, it highlights the importance of considering COVID-19 transmission in a range of workplaces and work roles. BioMed Central 2022-01-24 /pmc/articles/PMC8785373/ /pubmed/35073884 http://dx.doi.org/10.1186/s12889-021-12478-x Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Puchades, Alice
Daniel, Rhian
Geen, John
Peden, Jo
Lewis, Heather
Nnoaham, Kelechi
SARS-CoV-2 sero-prevalence in the workforces of three large workplaces in South Wales: a sero-epidemiological study
title SARS-CoV-2 sero-prevalence in the workforces of three large workplaces in South Wales: a sero-epidemiological study
title_full SARS-CoV-2 sero-prevalence in the workforces of three large workplaces in South Wales: a sero-epidemiological study
title_fullStr SARS-CoV-2 sero-prevalence in the workforces of three large workplaces in South Wales: a sero-epidemiological study
title_full_unstemmed SARS-CoV-2 sero-prevalence in the workforces of three large workplaces in South Wales: a sero-epidemiological study
title_short SARS-CoV-2 sero-prevalence in the workforces of three large workplaces in South Wales: a sero-epidemiological study
title_sort sars-cov-2 sero-prevalence in the workforces of three large workplaces in south wales: a sero-epidemiological study
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8785373/
https://www.ncbi.nlm.nih.gov/pubmed/35073884
http://dx.doi.org/10.1186/s12889-021-12478-x
work_keys_str_mv AT puchadesalice sarscov2seroprevalenceintheworkforcesofthreelargeworkplacesinsouthwalesaseroepidemiologicalstudy
AT danielrhian sarscov2seroprevalenceintheworkforcesofthreelargeworkplacesinsouthwalesaseroepidemiologicalstudy
AT geenjohn sarscov2seroprevalenceintheworkforcesofthreelargeworkplacesinsouthwalesaseroepidemiologicalstudy
AT pedenjo sarscov2seroprevalenceintheworkforcesofthreelargeworkplacesinsouthwalesaseroepidemiologicalstudy
AT lewisheather sarscov2seroprevalenceintheworkforcesofthreelargeworkplacesinsouthwalesaseroepidemiologicalstudy
AT nnoahamkelechi sarscov2seroprevalenceintheworkforcesofthreelargeworkplacesinsouthwalesaseroepidemiologicalstudy